General Information of Drug (ID:
DR2938) |
Drug Name |
AZD0328
|
Synonyms |
AR-R23465XX; AZD-0328; Spiro[1-azabicyclo[2.2.2]octane-8,8'-7-oxa-5-azabicyclo[4.3.0]nona-2,4,10-triene] |
Indication |
Alzheimer disease
[ICD11: 8A20]
|
Discontinued in Phase 2
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
216.28 |
Topological Polar Surface Area |
25.4 |
Heavy Atom Count |
16 |
Rotatable Bond Count |
0 |
Hydrogen Bond Donor Count |
0 |
Hydrogen Bond Acceptor Count |
3 |
Cross-matching ID |
- PubChem CID
- 9794392
- CAS Number
-
- TTD Drug ID
- D0Q9RR
- Formula
- C13H16N2O
- Canonical SMILES
- C1CN2CCC1[C@@]3(C2)CC4=C(O3)N=CC=C4
- InChI
- InChI=1S/C13H16N2O/c1-2-10-8-13(16-12(10)14-5-1)9-15-6-3-11(13)4-7-15/h1-2,5,11H,3-4,6-9H2/t13-/m0/s1
- InChIKey
- OCKIPDMKGPYYJS-ZDUSSCGKSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.